SCHEMBL7029384

SCHEMBL7029384

CCCCCOc1c(OC)ccc2c1CCN(CCc1ccc(OC(C)=O)cc1)C2=O

nearest known ligand 0.79

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 15/20 0.79
CNR1 P21554 1/20 0.39
ALOX5 P09917 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4409616 0.88 CNR2 (1.00) CNR2
SCHEMBL8089424 0.88 CNR2 (0.81) CNR2
SCHEMBL4409562 0.87 CNR2 (0.84) CNR2
SCHEMBL4417635 0.87 CNR2 (0.77) CNR2CNR1
SCHEMBL4418089 0.86 CNR2 (0.82) CNR2
SCHEMBL4411949 0.86 CNR2 (0.82) CNR2CNR1
SCHEMBL4414334 0.84 CNR2 (0.79) CNR2
SCHEMBL4417012 0.84 CNR2 (0.79) CNR2
SCHEMBL6363703 0.83 CNR2 (0.77) CNR2
SCHEMBL8085018 0.82 CNR2 (0.54) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002047691-A9 PROTECTION OF NEURONS AGAINST GLUTAMATE-INDUCED DAMAGE IN GLAUCOMA AND OTHER CONDITIONS AYOUB GEORGE S (US) 2003-11-20 WO disclosed
WO-2002047691-A1 PROTECTION OF NEURONS AGAINST GLUTAMATE-INDUCED DAMAGE IN GLAUCOMA AND OTHER CONDITIONS AYOUB GEORGE S (US) 2002-06-20 WO disclosed
US-20020077322-A1 Protection of neurons against glutamate-induced damage in glaucoma and other conditions AYOUB GEORGE S (US) 2002-06-20 US disclosed
US-6017919-A Compounds and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2000-01-25 US disclosed
EP-0887340-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 1998-12-30 EP disclosed